Patent: 6,291,223
Summary for Patent: 6,291,223
| Title: | Mouse aspartic secretase-1 (mASP1) |
| Abstract: | Mouse mASP1 polypeptides and polynucleotides and method for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for screening for compounds that either agonize or antagonize mouse mASP1. Such compounds are expected to be useful in treatment of human diseases, including, but not limited to: Alzheimer's disease, cancer, and prohormone processing. |
| Inventor(s): | Gary Christie, Xiaotong Li, David J. Powell, Yuan Zhu |
| Assignee: | SmithKline Beecham Ltd , SmithKline Beecham Corp |
| Application Number: | US09/717,432 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,291,223
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Bausch & Lomb Incorporated | VITRASE | hyaluronidase | Injection | 021640 | May 5, 2004 | ⤷ Start Trial | 2020-11-21 |
| Bausch & Lomb Incorporated | VITRASE | hyaluronidase | Injection | 021640 | December 2, 2004 | ⤷ Start Trial | 2020-11-21 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
